Cogstate (CGS)

Download button icon Download

Cogstate (CGS): Signals

No data currently available.

data-ad-format="auto">

Explore Compare Share

TECHNICAL ANALYSIS SUMMARY

Cogstate (CGS.AX)


Indicator:

TRIANGULAR MOVING AVERAGE


Last Signal:

BEARISH


Trading: SELL @ $0.215
Signal Strength: STRONG
Recommendation:

Indicator can be used in isolation or in additional to another technical indicator to confirmation for trading entry. This indicator has the ability to highlight trends across numerous timeframes. This indicator has the ability to smooth historical results to illustrate trend initiation and status. Although this is a simple trend following indicator & can provide good results when coupled with the right indicator. Note, this indicator does not work well in ranging markets producing unwanted whipsaws and false signals.


Cogstate (ASX:CGS) currently has a confirmed downtrend. Recent trading has caused the TMA 15 day average to move below the closing price confirming the short term trend following indicator. Currently, the return on TMA15 is -4.4%.



A triangular moving average can be calculated using various input data such as prices volume or another technical indicator.

Calculation: Triangular Moving Average (TMA):
1) SMA: n period sum / n;
2) TMA = (n SMA period sum) / N;


PROFILE: Cogstate (CGS.AX)


Stock Exchange: ASX
Company: Cogstate
Ticker Codes: | CGS.AX | ASX:CGS |

About Cogstate (ASX:CGS):

Cogstate Limited, a cognitive science company, provides computerized cognitive tests for clinical trials, academic research, healthcare, and brain injury applications primarily in Australia, the United States, and Europe. The company's services include scientific consultancy, project management, data management, statistical analysis, and reporting. It operates in three segments: Clinical Trials, Academic Research, and Healthcare. The Clinical Trials segment provides technology and associated services that are used to quantify the effect of disease and drugs, and devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical and biotechnology companies. The Academic Research segment offers technology and associated services to support international research studies and academic collaborations. As of June 30, 2017, it had participated in approximately 1,200 academic research studies in approximately 70 indications. The Healthcare segment provides Cognigram, a system that enables regular and standardized assessment of patients to detect cognitive decline. The company serves biopharmaceutical companies, sporting organizations, military, physicians and patients, academic institutions, and public-private partnerships. Cogstate Limited was founded in 1999 and is headquartered in Melbourne, Australia.

Top 10:

Triangular Moving Average

Download button icon Download
Company Close Change (%) Volume Value Signal
BKY Berkeley Resources 0.33 10 250,006 -16.7 BEARISH
SNZ Summerset Holdings 5.61 5.3 2,413 -8.7 BEARISH
GOR Gold Road Resources 0.93 3.4 1,393,557 -2.9 BEARISH
OGC Oceanagold Corporation 4.13 3 934,700 -6 BEARISH
FID Fiducian 4.71 2.8 4,048 -1.3 BEARISH
MAH Macmahon 0.21 2.5 4,361,956 -8.5 BEARISH
EDE Eden Energy 0.04 2.4 1,916,087 -2.3 BEARISH
FOR Forager Australian Shares 1.33 2.3 32,063 -2.9 BEARISH
SGM Sims 10.59 2.3 1,650,554 -2.6 BEARISH
PMC Platinum Capital 1.57 2.3 362,854 -2.2 BEARISH
back to top